Phase 3 study of ABP 215 meets its endpoints
Amgen and Allergan plc. announced on Wednesday that a Phase 3 study of biosimilar candidate ABP 215 met its primary…
Pharmaceuticals, Biotechnology and Life Sciences
Amgen and Allergan plc. announced on Wednesday that a Phase 3 study of biosimilar candidate ABP 215 met its primary…
ViiV Healthcare announced on Wednesday 24-week data from the Phase IIIb/IV Striiving study, an open-label study evaluating the efficacy, safety…
FDA is warning health care professionals about the risk for dosing errors with the intravenous antibacterial drug Avycaz (ceftazidime and…
US presidential candidate from Democratic party, Hilary Clinton, has announced to make a plan about pricing medicine. After the news spread…
Biofrontera, the biopharmaceutical company focusing on sun-induced skin cancer, has announced that preliminary long-term results of the Phase III trial for…
Bayer announced on September 22 that Bayer CropScience and the civil organization Round Table on Responsible (RTRS) are uniting to…
Allergan, a Dublin-headquartered pharmaceutical company, confirmed on Monday that it has filed an Abbreviated New Drug Application (ANDA) with the…
Allergan has announced a nationwide partnership with the Caregiver Action Network (CAN), a family caregiver organization, to provide thank you meals to 1,000…
The U.S. Food and Drug Administration (FDA) has announced that taking tramadol pain medicine for children under 17 can cause…
You must be logged in to post a comment.